Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2/6 ligand derived from cysteinyl-tRNA synthetase 1.
Kim HY, Cho S, Kim SB, Song EC, Jung W, Shin YG, Suh JH, Choi J, Yoon I, Kim U, Ban H, Hwang S, Mun J, Park J, Kim N, Lee Y, Kim MH, Kim S.
Kim HY, et al. Among authors: ban h.
Mol Ther. 2024 Oct 2;32(10):3597-3617. doi: 10.1016/j.ymthe.2024.07.014. Epub 2024 Jul 25.
Mol Ther. 2024.
PMID: 39066478
Free PMC article.